PTGS2 and sarcoma: Clinically, the antitumor effect of NSAIDs, including selective COX-2 inhibitors, for the treatment or prevention of some carcinomas has been reported [45], and the efficacy of the combination therapy with a selective COX-2 inhibitor and other chemotherapeutic agents has been reported in advanced sarcomas [46].